Researchers explore mechanisms behind different therapeutic profiles of anti-IL-23 antibodies May 25, 2022
Quoin enters research agreement with QUT to target VCAM-1:VL-4 interaction to treat scleroderma May 24, 2022
Kymera Therapeutics presents data on the IRAK4 degrader KT-474 in different cell subsets May 24, 2022
RSS